0 Комментарии
0 Поделились
276 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
What Are the Latest Treatment Advances for Metastatic Solid Tumors?According to the latest report published by Data Bridge Market Research, the Metastatic Solid Tumors Market CAGR Value The Metastatic Solid Tumors Market was valued at USD 73.86 billion in 2025 and is projected to reach USD 132.61 billion by 2033, growing at a CAGR of 7.59% from 2026 to 2033 The universal Metastatic Solid Tumors Market report has explained in-depth market...0 Комментарии 0 Поделились 153 Просмотры 0 предпросмотр
-
Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...0 Комментарии 0 Поделились 819 Просмотры 0 предпросмотр